Mouse models of myocardial CaMKII overexpression, without subcellular targeting, show activation of myocardial hypertrophy gene programs, increased cell death, fibrosis, chamber dilation, and premature death12,13. This evidence concerns the gene CAMK2G and cardiac hypertrophy.